Home / Verticals / Healthcare

Healthcare

Research Reports in Healthcare

Cold Pain Therapy Market

Cold Pain Therapy Market, Share and Segmentation, By Product (OTC Products, Gels, Ointments, & Creams, Sprays & Foams, Patches), By Application (Orthopedic Conditions, Post-operative Ther...

The Cold Pain Therapy Market Size was valued at USD 1.91 billion in 2023, and is expected to reach USD 2.96 billion by 2032, and grow at a CAGR of 5% over the forecast period 2024-2032.

Date: July 2023 | Report Code: SNS/HC/3292 | Pages: 147
Date: July 2023 | Report Code: SNS/HC/3292 | Pages: 147

Gene Therapy Market

Gene Therapy Market By Indication (Acute Lymphoblastic Leukemia (ALL), Inherited Retinal Disease, Large B-cell lymphoma, Melanoma (lesions), Beta-Thalassemia Major/SCD, Spinal Muscular At...

The Gene Therapy Market Size was valued at USD 9.2 Billion in 2023, and is expected to reach USD 54.39 Billion by 2032, and grow at a CAGR of 23.12%.

Date: July 2023 | Report Code: SNS/HC/3261 | Pages: 250
Date: July 2023 | Report Code: SNS/HC/3261 | Pages: 250

Human Papillomavirus (HPV) Vaccine Market

Human Papillomavirus (HPV) Vaccine Market Size, Share, & Segmentation By Type (Bivalent, Polyvalent), Disease Indication (HPV Related Cancer, Genital Warts), Distribution Channel (Hospita...

The human papillomavirus (HPV) vaccine market size was valued at USD 8.14 billion in 2024 and is expected to reach USD 27.36 billion by 2032.

Date: July 2023 | Report Code: SNS/HC/3260 | Pages: 260
Date: July 2023 | Report Code: SNS/HC/3260 | Pages: 260

Biomarkers Market

Biomarkers Market Size, Share and Segmentation By Product (Consumables, Services, Software), By Type, By Application, By Disease, By Regions | Global Forecast 2024-2032

The global biomarkers market is projected to grow from USD 67.92 billion in 2023 to USD 184.80 billion by 2032, at a CAGR of 11.78%.

Date: July 2023 | Report Code: SNS/HC/3257 | Pages: 300
Date: July 2023 | Report Code: SNS/HC/3257 | Pages: 300

Antiviral Drugs Market

Antiviral Drugs Market Size, Share & Segmentation, By Type (Branded, Generics), Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, and Neuramini...

The antiviral drugs market was valued at USD 57.32 billion in 2024 and is expected to reach USD 86.59 billion by 2032, with a CAGR of 5.5% from 2024-2032.

Date: July 2023 | Report Code: SNS/HC/3246 | Pages: 300
Date: July 2023 | Report Code: SNS/HC/3246 | Pages: 300

Bilirubin Blood Test Market

Bilirubin Blood Test Market, Share and Segmentation, By Test Type (Total Serum Bilirubin (Tsb), Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test), By Product Type (T...

The Bilirubin Blood Test Market Size was valued at USD 1.18 billion in 2023, and is expected to reach USD 2.11 billion by 2032, and grow at a CAGR of 6.7% over the forecast period 2024-2032.

Date: July 2023 | Report Code: SNS/HC/3245 | Pages: 146
Date: July 2023 | Report Code: SNS/HC/3245 | Pages: 146

Oncology Drugs Market

Oncology Drugs Market Size, Share & Segmentation By Drug Class [Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs], By Therapy [Chemotherapy, Targeted Therapy, Immunotherapy], By Indication...

The global Oncology Drugs Market size was USD 202.3 billion in 2023, is projected to reach USD 530.39 billion by 2032, growing at an 11.34% CAGR (2024-2032).

Date: July 2023 | Report Code: SNS/HC/3241 | Pages: 350
Date: July 2023 | Report Code: SNS/HC/3241 | Pages: 350

Bovine Mastitis Market

Bovine Mastitis Market Size, Share & Segmentation, By Product (Antibiotics, Other), By Route of Administration (Systemic, Intramammary), By Application (Veterinary Clinics and Hospitals, ...

The Bovine Mastitis Market size was USD 0.64 Billion in 2024 and is expected to reach USD 1.05 Billion by 2032 and grow at a CAGR of 6.4% over the forecast period of 2025-2032.

Date: July 2023 | Report Code: SNS/HC/3240 | Pages: 224
Date: July 2023 | Report Code: SNS/HC/3240 | Pages: 224

Recombinant Vaccines Market

Recombinant Vaccines Market By Type (Subunit and Live Attenuated), By Route of Administration (Parenteral and Oral), By Disease Indication (Human Papillomavirus (HPV), Hepatitis B, Rotavi...

The Recombinant Vaccines Market Size was valued at USD 12.53 Billion in 2023, and is expected to reach USD 32.83 Billion by 2032, and grow at a CAGR of 11.88%.

Date: July 2023 | Report Code: SNS/HC/3239 | Pages: 200
Date: July 2023 | Report Code: SNS/HC/3239 | Pages: 200

Ureteroscope Market

Ureteroscope Market Size, Share, & Segmentation By Product (Flexible, Semi-flexible, and Rigid), Application (Urolithiasis, Urolithial Cancer, and Others), End User (Hospitals, Specialty ...

The ureteroscope market size was valued at USD 1.33 billion in 2024 and is expected to reach USD 2.09 billion by 2032 and grow at a CAGR of 5.86%.

Date: July 2023 | Report Code: SNS/HC/3238 | Pages: 280
Date: July 2023 | Report Code: SNS/HC/3238 | Pages: 280